Mar 16, 2023 / 12:30PM GMT
Operator
Hello, and welcome to today's Pharming's Full Year 2022 Results Call. My name is Bailey, and I'll be the moderator for today's call. (Operator Instructions) I would now like to pass the conference over to your host, Sijmen de Vries, Chief Executive Officer. Please go ahead.
Sijmen de Vries - Pharming Group N.V. - President, CEO & Executive Director
Thank you very much, Bailey. Good morning or good afternoon, ladies and gentlemen, to our 2022 results call. I would like to start taking you through that.
But before I do that, I would like to -- you to pay attention to the next slide, which contains a statement on forward-looking -- on forward-looking statements, as we may be making forward-looking statements in this conversation. They are statements based upon our expectations and assumptions and involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in these statements, and you can read the rest for yourself, I assume.
I'm today here --
Q4 2022 Pharming Group NV Earnings Call Transcript
Mar 16, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers